Changes involving T cell cytokine levels, differential cell counts, inflammatory mediators, etc., in bronchoalveolar lavage fluid (BALF), as well as systemic immune responses in asthmatic subjects, may reflect the status of an asthma attack and the effectiveness of asthma management through either classical or alternative therapies [1]. This evidence concerns the gene TBXT and asthma.